William G. Kerr

Dr. William G. Kerr


Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2005 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MKMarcin Kortylewski
Marcin Kortylewski
MKMaciej Kujawski
Maciej Kujawski
TWTianhong Wang
Tianhong Wang
SWSheng Wei
Sheng Wei
SZShumin Zhang
Shumin Zhang
HYHua Yu
Hua Yu

15 April 1997 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BZBrian P. Zambrowicz
Brian P. Zambrowicz
AIAkira Imamoto
Akira Imamoto
SFSteve Fiering
Steve Fiering
LHLeonard A. Herzenberg
Leonard A. Herzenberg
WKWilliam G. Kerr
William G. Kerr
PSPhilippe Soriano
Philippe Soriano
The ROSAβgeo26 (ROSA26) mouse strain was produced by random retroviral gene trapping in embryonic stem cells. Staining of ROSA26 tissues and fluorescence-activated cell sorter-Gal analysis of hematopoietic cells demonstrates ubiquitous expression of the proviral βgeo reporter gene, and bone marrow transfer experiments illustrate the general utility of this strain for chimera and transplantation studies. The gene trap vector has integrated into a region that produces three transcripts. Two transcripts, lost in ROSA26 homozygous animals, originate from a common promoter and share identical 5′ ends, but neither contains a significant ORF. The third transcript, originating from the reverse strand, shares antisense sequences with one of the noncoding transcripts. This third transcript potentially encodes a novel protein of at least 505 amino acids that is conserved in humans and in Caenorhabditis elegans .

18 May 2010 in Science Signaling
Verified
Journal Article
Closed access
PDF file
QPQisheng Peng
Qisheng Peng
SMShikha Malhotra
Shikha Malhotra
JTJames A. Torchia
James A. Torchia
WKWilliam G. Kerr
William G. Kerr
KCK. Mark Coggeshall
K. Mark Coggeshall
MHMary Beth Humphrey
Mary Beth Humphrey
The activation and fusion of macrophages and of osteoclasts require the adaptor molecule DNAX-activating protein of 12 kD (DAP12), which contains immunoreceptor tyrosine-based activation motifs (ITAMs). TREM2 (triggering receptor expressed on myeloid cells–2) is the main DAP12-associated receptor in osteoclasts and, similar to DAP12 deficiency, loss of TREM2 in humans leads to Nasu-Hakola disease, which is characterized by bone cysts and dementia. Furthermore, in vitro experiments have shown that deficiency in DAP12 or TREM2 leads to impaired osteoclast development and the formation of mononuclear osteoclasts. Here, we demonstrate that the ligation of TREM2 activated phosphatidylinositol 3-kinase (PI3K), extracellular signal–regulated kinase 1 (ERK1) and ERK2, and the guanine nucleotide exchange factor Vav3; induced the mobilization of intracellular calcium (Ca2+) and the reorganization of actin; and prevented apoptosis. The signaling adaptor molecule DAP10 played a key role in the TREM2- and DAP12-dependent recruitment of PI3K to the signaling complex. Src homology 2 (SH2) domain–containing inositol phosphatase-1 (SHIP1) inhibited TREM2- and DAP12-induced signaling by binding to DAP12 in an SH2 domain–dependent manner and preventing the recruitment of PI3K to DAP12. These results demonstrate a previously uncharacterized interaction of SHIP1 with DAP12 that functionally limits TREM2- and DAP12-dependent signaling and identify a mechanism through which SHIP1 regulates key ITAM-containing receptors by directly blocking the binding and activation of PI3K.

1 September 2003 in Immunity
Verified
Journal Article
Closed access
FCFengdong Cheng
Fengdong Cheng
HWHong-Wei Wang
Hong-Wei Wang
ACAlex Cuenca
Alex Cuenca
MHMei Huang
Mei Huang
TGTomar Ghansah
Tomar Ghansah
ESEduardo M. Sotomayor
Eduardo M. Sotomayor

15 March 2002 in Science
Verified
Journal Article
Closed access
PDF file
JWJia-Wang Wang
Jia-Wang Wang
JHJulie M. Howson
Julie M. Howson
TGTomar Ghansah
Tomar Ghansah
CDCaroline Desponts
Caroline Desponts
JNJohn M. Ninos
John M. Ninos
WKWilliam G. Kerr
William G. Kerr
Natural killer cell (NK) receptors for major histocompatibility complex (MHC) class I influence engraftment and graft-versus-tumor effects after allogeneic bone marrow transplantation. We find that SH2-containing inositol phosphatase (SHIP) influences the repertoire of NK receptors. In adult SHIP −/− mice, the NK compartment is dominated by cells that express two inhibitory receptors capable of binding either self or allogeneic MHC ligands. This promiscuous repertoire has significant functional consequences, because SHIP −/− mice fail to reject fully mismatched allogeneic marrow grafts and show enhanced survival after such transplants. Thus, SHIP plays an important role in two processes that limit the success of allogeneic marrow transplantation: graft rejection and graft-versus-host disease.

1 April 2010 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
RBRobert Brooks
Robert Brooks
GFGwenny M. Fuhler
Gwenny M. Fuhler
SISonia Iyer
Sonia Iyer
MSMichelle J. Smith
Michelle J. Smith
MPMi-Young Park
Mi-Young Park
WKWilliam G. Kerr
William G. Kerr
Genetic studies revealed that SHIP1 limits blood cell production and immune regulatory cell numbers in vivo. We postulated that molecular targeting of SHIP1 might enhance blood cell production and increase immunoregulatory capacity. In this study, we report the identification of a chemical inhibitor of SHIP1, 3 α-aminocholestane (3AC). Treatment with 3AC significantly expands the myeloid immunoregulatory cell compartment and impairs the ability of peripheral lymphoid tissues to prime allogeneic T cell responses. In addition, 3AC treatment profoundly increases granulocyte production without triggering the myeloid-associated lung consolidation observed in SHIP1−/− mice. Moreover, 3AC also enhances RBC, neutrophil, and platelet recovery in myelosuppressed hosts. Intriguingly, we also find that chemical inhibition of SHIP1 triggers apoptosis of blood cancer cells. Thus, SHIP1 inhibitors represent a novel class of small molecules that have the potential to enhance allogeneic transplantation, boost blood cell production, and improve the treatment of hematologic malignancies.